Company / EPS (Diluted)
HERBALIFE LTD. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.42
FY2025
5-year range
$1.42 / $4.13
FY2021-FY2025
Trend
-56.0%
vs FY2024
Sector context
#67 of 159
Health Care
What the data says
At $1.42, HERBALIFE LTD.'s eps (diluted) ranks #67 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $1.29 in FY2019 to $4.13 in FY2023.
Based on SEC 10-K filings.
1.42 in FY2025 with a 5-year CAGR of -6.4%.
Declined from $4.13 to $1.42 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -6.4%
- 10-Year CAGR
- -
Sector benchmark
#67 of 159 in Health CareTop 42% of 159This company $1.42 Sector average $1.67
▼
-14.9% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 56.0% year-over-year.
- Ranks #67 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2023.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.42 | -56.0% |
| FY2024 | $3.23 | -21.8% |
| FY2023 | $4.13 | +49.1% |
| FY2022 | $2.77 | +25.9% |
| FY2021 | $2.20 | +11.1% |
| FY2020 | $1.98 | +53.5% |
| FY2019 | $1.29 | -14.6% |
| FY2018 | $1.51 | -62.0% |
| FY2017 | $3.97 | +16.8% |
| FY2016 | $3.40 | -30.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026